浸润性黏液性卵巢癌保留生育功能治疗的安全性
本研究回顾性分析1999至2019年两家三级癌症中心确诊的浸润性黏液性卵巢癌,比较保留生育功能手术与根治性手术的生存结局。在134例I期患者中,42例(31%)接受保留生育功能手术,两组总生存期和无复发生存期无差异, multivariable分析显示保留生育功能手术与总生存期(HR 0.18;95%CI 0.01-2.78)和无复发生存期(HR 0.19;95%CI 0.03-1.45)无显著关联。作者认为对希望保留生育功能的早期患者,保留生育功能手术是合理的。
要点
- I期浸润性黏液性卵巢癌中,31%(42/134)接受保留生育功能手术。
- 保留生育功能手术组2例(5%)复发,其中1例死于疾病进展。
- 保留生育功能手术与根治性手术相比,总生存期和无复发生存期无差异。
核心结论
- I期浸润性黏液性卵巢癌行保留生育功能手术与根治性手术相比结局不更差,对希望保留生育功能的早期患者是合理的。
研究设计与样本
- 回顾性审查1999年至2019年两家三级癌症中心确诊的浸润性黏液性卵巢癌,病理复核排除胃肠道转移,比较保留生育功能手术与根治性手术(至少子宫全切、双侧输卵管卵巢切除±分期)的人口学和生存结局,构建Cox比例风险模型评估保留生育功能手术对生存的影响。
主要发现
- 134例I期患者中42例(31%)接受保留生育功能手术(单侧输卵管卵巢切除),与根治性手术组相比更年轻、低级别、早期疾病。
- 保留生育功能手术组2例(5%)复发,其中1例死于疾病进展。
- 调整年龄和辅助化疗使用后,保留生育功能手术与总生存期(HR 0.18;95%CI 0.01-2.78)和无复发生存期(HR 0.19;95%CI 0.03-1.45)无显著关联。
- 4例(9%)记录到足月分娩,中位受孕间隔11个月。
临床怎么用
- 作者认为对希望保留生育功能的I期浸润性黏液性卵巢癌患者,提供保留生育功能手术是合理的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of the study was to evaluate the safety of fertility-sparing surgery in invasive mucinous ovarian carcinomas (MOC). METHODS: Retrospective review was performed of MOCs diagnosed between 1999 and 2019 at two tertiary cancer centers. Pathology was reviewed to rule out metastasis from gastrointestinal tract. The demographics and survival outcomes were compared between women who underwent fertility-sparing surgery and those who underwent radical surgery (at least hysterectomy, bilateral salpingo-oophorectomy +/- staging). Cox proportional hazard models were constructed to evaluate the effect of fertility sparing surgery on survival. RESULTS: Of 134 with stage I disease, 42 (31%) underwent fertility-sparing surgery with unilateral salpingo-oophorectomy. Compared to women who underwent radical surgery, these women were younger with low grade, early-stage disease. Two patients (5%) in the fertility-sparing cohort experienced a recurrence and 1 of these 2 patients died due to disease progression. There was no difference in either OS or RFS between those that underwent fertility-sparing surgery and radical surgery. In a multivariable analysis adjusting for age and use of adjuvant chemotherapy, fertility-sparing surgery was not significantly associated with OS (HR 0.18; 95% CI 0.01-2.78) or RFS (HR 0.19; 95% CI 0.03-1.45). There were 4 patients (9%) with documented full-term delivery with median interval to conception of 11 months. CONCLUSIONS: Fertility-sparing surgery in stage I MOC is not associated with worse outcomes compared to radical surgery and is reasonable to offer to those with early stage disease who wish to retain fertility.
引用
- Kim SR, Madariaga A, Hogen L, et al. Safety of fertility sparing management in invasive mucinous ovarian carcinoma. Gynecol Oncol. 2023. PMID: 37182433. doi:10.1016/j.ygyno.2023.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。